Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)

PHASE3CompletedINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

March 8, 2022

Primary Completion Date

August 19, 2023

Study Completion Date

June 1, 2024

Conditions
Palmoplantar Pustulosis
Interventions
DRUG

Apremilast

Oral tablets

DRUG

Placebo

Oral tablets

Trial Locations (40)

480-1195

Aichi Medical University Hospital, Nagakute-shi

467-8602

Nagoya City University Hospital, Nagoya

285-8741

Toho University Sakura Medical Center, Sakura-shi

791-0295

Ehime University Hospital, Toon-shi

811-1302

Kusuhara Dermatology Clinic, Fukuoka

814-0180

Fukuoka University Hospital, Fukuoka

816-0802

Higuchi Dermatology Urology Clinic, Kasuga-shi

830-0011

Kurume University Hospital, Kurume-shi

838-0144

Nagata Dermatology Clinic, Ogori-shi

960-1295

Fukushima Medical University Hospital, Fukushima

505-8510

Central Japan International Medical Center, Minokamo-shi

070-0810

Motomachi Dermatology Clinic, Asahikawa-shi

078-8510

Asahikawa Medical University Hospital, Asahikawa-shi

066-0021

Medical corporation kojinkai Chitose dermatology and plastic surgery clinic, Chitose-shi

002-8022

Shinoro Dermatology Clinic, Sapporo

003-0833

Medical Corporation Kojinkai Kitago Dermatology Clinic, Sapporo

006-0022

Shibaki Dermatology Clinic, Sapporo

060-0063

Medical Corporation Kojinkai Sapporo Skin Clinic, Sapporo

650-0017

Kobe University Hospital, Kobe

310-0015

Mito Kyodo General Hospital, Mito

920-8530

Ishikawa Prefectural Central Hospital, Kanazawa

760-0017

Takamatsu Red Cross Hospital, Takamatsu

890-8520

Kagoshima University Hospital, Kagoshima

221-0825

Nomura Dermatology Clinic, Yokohama

783-8505

Kochi Medical School Hospital, Nankoku-shi

940-2085

Nagaoka Red Cross Hospital, Nagaoka-shi

879-5593

Oita University Hospital, Yufu-shi

550-0006

Nippon Life Hospital, Osaka

554-0021

Medical Corporation Goto Dermatology Clinic, Osaka

593-8324

Dermatology and Ophthalmology Kume Clinic, Sakai-shi

569-0824

Yoshikawa Skin Clinic, Takatsuki-shi

343-8555

Dokkyo Medical University Saitama Medical Center, Koshigaya-shi

330-0064

Pansy Skin Clinic, Saitama-shi

329-0498

Jichi Medical University Hospital, Shimotsuke-shi

102-8798

Tokyo Teishin Hospital, Chiyoda-ku

173-8606

Teikyo University Hospital, Itabashi-ku

173-8610

Nihon University Itabashi Hospital, Itabashi-ku

160-0023

Tokyo Medical University Hospital, Shinjuku-ku

161-8521

Seibo International Catholic Hospital, Shinjuku-ku

400-8506

Yamanashi Prefectural Central Hospital, Kofu

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY

NCT05174065 - Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP) | Biotech Hunter | Biotech Hunter